Latest Insights in Events
Llusern to attend WHX Dubai 9-12 February 2026
Next month Llusern Scientific will be at WHX 2026 as part of the Welsh Government trade mission travelling to the…
Lodestar UTI to be presented at two major urology congresses
Llusern Scientific is delighted to announce that Lodestar DX will be present at two leading urology conferences in 2026. The…
New webinar: A real-world performance study of the Lodestar UTI testing system
Following the success of our first Lodestar DX webinar we are pleased to share that we will be hosting another…
Bio 2024, San Diego
Llusern Scientific will be taking its first steps onto American soil in June of this year. We will be attending…
Poster presentations at BSAC UTI conference
Llusern Scientific is delighted to announce that two abstracts have been accepted for poster presentation at the British Society for…
Llusern at ECCMID23 in Copenhagen
Dr Emma Hayhurst will be presenting the latest data from Llusern’s work in developing fast and accurate point-of-care UTI testing…
Start a conversation with Llusern
Llusern is developing treatment-directing diagnostics for high-volume healthcare challenges, starting with rapid molecular UTI testing. To learn more about the company, the product and the opportunity ahead, speak to the Llusern team.
